Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The impact of paced QRS duration on the expression of genes related to contractile function of the left ventricle in chronically paced patients from the right ventricular apex.

Simantirakis Ε, Arkolaki E, Kontaraki J, Chlouverakis G, Mavrakis H, Kallergis E, Parthenakis F, Vardas P.

Hellenic J Cardiol. 2019 Apr 26. pii: S1109-9666(19)30002-8. doi: 10.1016/j.hjc.2019.04.011. [Epub ahead of print]

2.

Platelet microRNAs in hypertensive patients with and without cardiovascular disease.

Marketou M, Kontaraki J, Papadakis J, Kochiadakis G, Vrentzos G, Maragkoudakis S, Fragkiadakis K, Katsouli E, Plataki M, Patrianakos A, Chlouverakis G, Papanikolaou K, Vardas P, Parthenakis F.

J Hum Hypertens. 2019 Feb;33(2):149-156. doi: 10.1038/s41371-018-0123-5. Epub 2018 Oct 30.

PMID:
30375479
3.

The long non-coding RNAs MHRT, FENDRR and CARMEN, their expression levels in peripheral blood mononuclear cells in patients with essential hypertension and their relation to heart hypertrophy.

Kontaraki JE, Marketou ME, Kochiadakis GE, Maragkoudakis S, Konstantinou J, Vardas PE, Parthenakis FI.

Clin Exp Pharmacol Physiol. 2018 Nov;45(11):1213-1217. doi: 10.1111/1440-1681.12997.

PMID:
29917257
4.

MicroRNAs in Peripheral Mononuclear Cells as Potential Biomarkers in Hypertensive Patients With Heart Failure With Preserved Ejection Fraction.

Marketou ME, Kontaraki JE, Maragkoudakis S, Patrianakos A, Konstantinou J, Nakou H, Vougia D, Logakis J, Chlouverakis G, Vardas PE, Parthenakis FI.

Am J Hypertens. 2018 May 7;31(6):651-657. doi: 10.1093/ajh/hpy035.

PMID:
29506053
5.

Bradykinin receptors gene expression in white adipose tissue in nondiabetic patients with coronary artery disease.

Marketou ME, Kochiadakis G, Kontaraki J, Zacharis E, Kanoupakis E, Kallergis E, Mavrakis H, Tsiverdis P, Lempidakis D, Konstantinou J, Fragkiadakis K, Chlouverakis G, Vardas P, Parthenakis F.

Coron Artery Dis. 2018 Jun;29(4):329-335. doi: 10.1097/MCA.0000000000000604.

PMID:
29334504
6.

Increased platelet alpha2B-adrenergic receptor gene expression in well-controlled hypertensives: the effect of arterial stiffness.

Marketou ME, Kontaraki JE, Papadakis JA, Vrentzos GE, Patrianakos A, Fragkiadakis K, Tsiverdis P, Lempidakis D, Chlouverakis G, Vardas PE, Parthenakis FI.

J Am Soc Hypertens. 2017 Nov;11(11):762-768. doi: 10.1016/j.jash.2017.08.006. Epub 2017 Aug 26.

PMID:
28923554
7.

Low Levels of MicroRNA-21 Are a Marker of Reduced Arterial Stiffness in Well-Controlled Hypertension.

Parthenakis F, Marketou M, Kontaraki J, Patrianakos A, Nakou H, Touloupaki M, Vernardos M, Kochiadakis G, Chlouverakis G, Vardas P.

J Clin Hypertens (Greenwich). 2017 Mar;19(3):235-240. doi: 10.1111/jch.12900. Epub 2016 Aug 22.

8.

Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients.

Parthenakis FI, Marketou ME, Kontaraki JE, Maragoudakis F, Maragkoudakis S, Nakou H, Roufas K, Patrianakos A, Chlouverakis G, Malliaraki N, Vardas PE.

J Hum Hypertens. 2016 Nov;30(11):685-689. doi: 10.1038/jhh.2016.15. Epub 2016 Mar 17.

PMID:
26984682
9.

Endothelial progenitor cells as markers of severity in hypertrophic cardiomyopathy.

Kalyva A, Marketou ME, Parthenakis FI, Pontikoglou C, Kontaraki JE, Maragkoudakis S, Petousis S, Chlouverakis G, Papadaki HA, Vardas PE.

Eur J Heart Fail. 2016 Feb;18(2):179-84. doi: 10.1002/ejhf.436. Epub 2015 Dec 23.

10.

Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension.

Kontaraki JE, Marketou ME, Parthenakis FI, Maragkoudakis S, Zacharis EA, Petousis S, Kochiadakis GE, Vardas PE.

J Am Soc Hypertens. 2015 Oct;9(10):802-810. doi: 10.1016/j.jash.2015.07.013. Epub 2015 Aug 1.

PMID:
26358152
11.

Alterations in the expression of genes related to contractile function and hypertrophy of the left ventricle in chronically paced patients from the right ventricular apex.

Arkolaki EG, Simantirakis EN, Kontaraki JE, Chrysostomakis SI, Patrianakos AP, Chlouverakis GI, Nakou ES, Vardas PE.

Europace. 2015 Oct;17(10):1563-70. doi: 10.1093/europace/euv071. Epub 2015 Apr 6.

PMID:
25851726
12.

Circulating mesenchymal stem cells in patients with hypertrophic cardiomyopathy.

Marketou ME, Parthenakis FI, Kalyva A, Pontikoglou C, Maragkoudakis S, Kontaraki JE, Zacharis EA, Patrianakos A, Chlouverakis G, Papadaki HA, Vardas PE.

Cardiovasc Pathol. 2015 May-Jun;24(3):149-53. doi: 10.1016/j.carpath.2015.02.005. Epub 2015 Feb 23.

PMID:
25744383
13.

Increased mobilization of mesenchymal stem cells in patients with essential hypertension: the effect of left ventricular hypertrophy.

Marketou ME, Parthenakis FI, Kalyva A, Pontikoglou C, Maragkoudakis S, Kontaraki JE, Zacharis EA, Chlouverakis G, Patrianakos A, Papadaki HA, Vardas PE.

J Clin Hypertens (Greenwich). 2014 Dec;16(12):883-8. doi: 10.1111/jch.12426. Epub 2014 Oct 20.

14.

MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage.

Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE.

J Am Soc Hypertens. 2014 Jun;8(6):368-75. doi: 10.1016/j.jash.2014.03.324. Epub 2014 Mar 27.

PMID:
24794206
15.

Biochemical characterisation of Troponin C mutations causing hypertrophic and dilated cardiomyopathies.

Kalyva A, Parthenakis FI, Marketou ME, Kontaraki JE, Vardas PE.

J Muscle Res Cell Motil. 2014 Apr;35(2):161-78. doi: 10.1007/s10974-014-9382-0. Epub 2014 Apr 18. Review.

PMID:
24744096
16.

Early cardiac gene transcript levels in peripheral blood mononuclear cells reflect severity in stable coronary artery disease.

Kontaraki JE, Kochiadakis GE, Marketou ME, Chlouverakis G, Igoumenidis NE, Saloustros IG, Vardas PE.

Hellenic J Cardiol. 2014 Mar-Apr;55(2):119-25.

17.

Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness.

Marketou ME, Kalyva A, Parthenakis FI, Pontikoglou C, Maragkoudakis S, Kontaraki JE, Chlouverakis G, Zacharis EA, Patrianakos A, Papadaki HA, Vardas PE.

J Clin Hypertens (Greenwich). 2014 Apr;16(4):295-300. doi: 10.1111/jch.12287. Epub 2014 Mar 19.

18.

Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertension.

Marketou ME, Kontaraki J, Zacharis E, Parthenakis F, Maragkoudakis S, Gavras I, Gavras H, Vardas PE.

J Hum Hypertens. 2014 Jul;28(7):450-5. doi: 10.1038/jhh.2013.133. Epub 2014 Jan 9.

PMID:
24401952
19.

Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension.

Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE.

J Hum Hypertens. 2014 Aug;28(8):510-6. doi: 10.1038/jhh.2013.117. Epub 2013 Nov 28.

PMID:
24284386
20.

Blockade of platelet alpha2B-adrenergic receptors: a novel antiaggregant mechanism.

Marketou ME, Kintsurashvili E, Androulakis NE, Kontaraki J, Alexandrakis MG, Gavras I, Vardas PE, Gavras H.

Int J Cardiol. 2013 Oct 3;168(3):2561-6. doi: 10.1016/j.ijcard.2013.03.051. Epub 2013 Apr 10.

PMID:
23582690
21.

TLR2 and TLR4 gene expression in peripheral monocytes in nondiabetic hypertensive patients: the effect of intensive blood pressure-lowering.

Marketou ME, Kontaraki JE, Zacharis EA, Kochiadakis GE, Giaouzaki A, Chlouverakis G, Vardas PE.

J Clin Hypertens (Greenwich). 2012 May;14(5):330-5. doi: 10.1111/j.1751-7176.2012.00620.x. Epub 2012 Apr 17.

22.

Early cardiac gene transcript levels in peripheral blood mononuclear cells in patients with untreated essential hypertension.

Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE.

J Hypertens. 2011 Apr;29(4):791-7. doi: 10.1097/HJH.0b013e3283424bc4.

PMID:
21157370
23.

Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension.

Marketou ME, Kontaraki JE, Tsakountakis NA, Zacharis EA, Kochiadakis GE, Arfanakis DA, Parthenakis F, Chlouverakis G, Vardas PE.

Am J Cardiol. 2011 Jan;107(1):59-63. doi: 10.1016/j.amjcard.2010.08.048.

PMID:
21146687
24.

Myocardial gene expression alterations in peripheral blood mononuclear cells of patients with idiopathic dilated cardiomyopathy.

Kontaraki JE, Parthenakis FI, Nyktari EG, Patrianakos AP, Vardas PE.

Eur J Heart Fail. 2010 Jun;12(6):541-8. doi: 10.1093/eurjhf/hfq057. Epub 2010 Apr 13.

25.

Arterial stiffness in hypertensives in relation to expression of angiopoietin-1 and 2 genes in peripheral monocytes.

Marketou ME, Kontaraki JE, Tsakountakis NA, Zacharis EA, Kochiadakis GE, Arfanakis DA, Chlouverakis G, Vardas PE.

J Hum Hypertens. 2010 May;24(5):306-11. doi: 10.1038/jhh.2009.95. Epub 2010 Jan 14.

PMID:
20072144
26.

Myocardin gene regulatory variants as surrogate markers of cardiac hypertrophy - study in a genetically homogeneous population.

Kontaraki JE, Parthenakis FI, Patrianakos AP, Karalis IK, Vardas PE.

Clin Genet. 2008 Jan;73(1):71-8. Epub 2007 Nov 19.

PMID:
18028454
27.

Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy.

Kontaraki JE, Parthenakis FI, Patrianakos AP, Karalis IK, Vardas PE.

Cardiovasc Pathol. 2007 Nov-Dec;16(6):329-35. Epub 2007 Jun 20.

PMID:
18005871
29.

Terminal transferase-dependent PCR (TDPCR) for in vivo UV photofootprinting of vertebrate cells.

Chen HH, Kontaraki J, Bonifer C, Riggs AD.

Sci STKE. 2001 Apr 10;2001(77):pl1.

PMID:
11752648
30.
32.

Assignment of a human cold shock domain protein A intronless pseudogene (CSDAP1) to human chromosome 16 band p11.2 by in situ hybridization.

Argyrokastritis A, Kontaraki J, Kamakari S, Pasparaki A, Moschonas NK.

Cytogenet Cell Genet. 1999;84(1-2):53-4. No abstract available.

PMID:
10343102

Supplemental Content

Loading ...
Support Center